RhumbLine Advisers’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $328K | Sell |
|
|||||
|
2025
Q1 | $418K | Sell |
|
|||||
|
2024
Q4 | $639K | Buy |
|
|||||
|
2024
Q3 | $588K | Sell |
|
|||||
|
2024
Q2 | $618K | Buy |
|
|||||
|
2024
Q1 | $573K | Buy |
|
|||||
|
2023
Q4 | $624K | Buy |
|
|||||
|
2023
Q3 | $410K | Sell |
|
|||||
|
2023
Q2 | $604K | Sell |
|
|||||
|
2023
Q1 | $669K | Buy |
|
|||||
|
2022
Q4 | $699K | Buy |
|
|||||
|
2022
Q3 | $823K | Buy |
|
|||||
|
2022
Q2 | $564K | Buy |
|
|||||
|
2022
Q1 | $733K | Buy |
|
|||||
|
2021
Q4 | $955K | Buy |
|
|||||
|
2021
Q3 | $131K | Buy |
|